166 related articles for article (PubMed ID: 35008393)
1. Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography-Mass Spectrometry-Based Metabolomics.
Fang C; Wang H; Lin Z; Liu X; Dong L; Jiang T; Tan Y; Ning Z; Ye Y; Tan G; Xu G
Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008393
[TBL] [Abstract][Full Text] [Related]
2. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
3. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma.
Wang Q; Tan Y; Jiang T; Wang X; Li Q; Li Y; Dong L; Liu X; Xu G
Cells; 2022 Mar; 11(7):. PubMed ID: 35406630
[TBL] [Abstract][Full Text] [Related]
5. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
[TBL] [Abstract][Full Text] [Related]
6. Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming.
Zhang F; Wang Y; Chen G; Li Z; Xing X; Putz-Bankuti C; Stauber RE; Liu X; Madl T
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33924061
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
8. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.
Liu SY; Zhang RL; Kang H; Fan ZJ; Du Z
World J Gastroenterol; 2013 Jun; 19(22):3423-32. PubMed ID: 23801834
[TBL] [Abstract][Full Text] [Related]
9. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
10. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
[TBL] [Abstract][Full Text] [Related]
11. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
[TBL] [Abstract][Full Text] [Related]
12. Liquid Chromatography-Mass Spectrometry-Based Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection.
Wang Q; Su B; Dong L; Jiang T; Tan Y; Lu X; Liu X; Lin X; Xu G
J Proteome Res; 2020 Aug; 19(8):3533-3541. PubMed ID: 32618195
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
15. An optimized analytical method for cellular targeted quantification of primary metabolites in tricarboxylic acid cycle and glycolysis using gas chromatography-tandem mass spectrometry and its application in three kinds of hepatic cell lines.
Xu J; Zhai Y; Feng L; Xie T; Yao W; Shan J; Zhang L
J Pharm Biomed Anal; 2019 Jul; 171():171-179. PubMed ID: 31005043
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure.
Wang S; Yang X; Liu F; Wang X; Zhang X; He K; Wang H
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34072178
[TBL] [Abstract][Full Text] [Related]
17. Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
Tang L; Zeng J; Geng P; Fang C; Wang Y; Sun M; Wang C; Wang J; Yin P; Hu C; Guo L; Yu J; Gao P; Li E; Zhuang Z; Xu G; Liu Y
Clin Cancer Res; 2018 Jan; 24(2):474-485. PubMed ID: 29084919
[No Abstract] [Full Text] [Related]
18. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
19. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases.
Zhou L; Wang Q; Yin P; Xing W; Wu Z; Chen S; Lu X; Zhang Y; Lin X; Xu G
Anal Bioanal Chem; 2012 Apr; 403(1):203-13. PubMed ID: 22349331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
